Complaint handling and post-market surveillance are critical elements of medical device quality systems. While design controls ensure devices are properly developed and manufactured, complaint handling ensures that real-world performance is continuously monitored after the device reaches patients and users.

Under the legacy Quality System Regulation (QSR), complaint handling requirements were defined in 21 CFR §820.198, which required manufacturers to establish procedures for receiving, reviewing, and evaluating complaints.

With the transition to the Quality Management System Regulation (QMSR) and its alignment with ISO 13485:2016, these responsibilities remain fundamentally the same, but the expectations increasingly emphasize systematic monitoring of device performance and integration with risk management and CAPA processes.

In short, complaint handling is no longer just a regulatory requirement, it is a key component of post-market intelligence about device performance and safety.

What Constitutes a Complaint?

A complaint is typically defined as any written, electronic, or oral communication alleging deficiencies related to the identity, quality, durability, reliability, safety, effectiveness, or performance of a device after it has been released for distribution.

Examples of complaints may include device malfunction or failure, labeling or instructions issues, adverse events or patient injuries, usability concerns, or device performance concerns raised by clinicians or users.

Organizations must ensure that all complaints are formally documented, evaluated, and processed according to established procedures. Failure to capture complaints consistently is a common issue identified during regulatory inspections.

Complaint Evaluation and Investigation

Once a complaint is received, it must be evaluated to determine whether an investigation is necessary.

Factors influencing investigation decisions may include severity of the reported issue, potential impact on device safety or performance, frequency of similar complaints, and information already available about the issue.

If an investigation is performed, the manufacturer must document the nature of the complaint, investigation results, root cause findings, and corrective actions taken (if applicable).

Even when no investigation is performed, the rationale for that decision must be documented.

Complaint evaluation and investigation documentation is frequently reviewed during FDA inspections.

Medical Device Reporting (MDR)

One of the most important elements of complaint handling is determining whether a complaint meets the criteria for Medical Device Reporting (MDR) under 21 CFR Part 803.

Manufacturers are required to report certain events to FDA when a device may have caused or contributed to a death or serious injury or has malfunctioned in a way that could lead to serious harm if the malfunction were to recur.

Complaint handling procedures must therefore include mechanisms for timely MDR evaluation and submission when required. Failure to properly identify and report MDR events is a frequent cause of FDA Warning Letters.

Trending and Post-Market Data Analysis

Under ISO-aligned quality systems, complaint handling is closely connected to data analysis and trending. Manufacturers should regularly analyze complaint data to identify patterns that may indicate emerging quality issues.

Trending activities may include identifying increases in complaint frequency, monitoring recurring device failures, identifying geographic or customer-specific trends, and evaluating links between complaints and supplier components.

These analyses help organizations detect potential systemic issues before they escalate into larger regulatory or safety problems. When patterns emerge, the organization may initiate CAPA investigations or update risk management assessments.

Integration with Risk Management

One of the most important conceptual shifts under ISO-aligned quality systems is the integration of post-market information with risk management activities.

Complaint data can provide valuable insights into previously unidentified hazards, underestimated risks, and the effectiveness of risk control measures.

Under ISO 14971 principles, manufacturers should periodically evaluate whether real-world device performance requires updates to hazard analyses, risk evaluations, and risk control strategies.

This feedback loop helps ensure that risk management remains a living process rather than a one-time design exercise.

Post-Market Surveillance in the QMSR Framework

Post-market surveillance extends beyond complaint handling to include broader monitoring of device performance in the field.

Sources of post-market information may include complaint records, service reports, returned product evaluations, literature reviews, adverse event databases, and customer feedback.

By combining these data sources, manufacturers gain a more comprehensive understanding of how devices perform under real-world conditions. This broader surveillance framework aligns closely with international regulatory expectations, including those found in the European Medical Device Regulation (EU MDR).

Complaint Handling in FDA Inspections

FDA investigators routinely examine complaint handling systems during inspections. Typical inspection questions include “Are complaints consistently documented?” “Are investigations performed when required?” “Are MDR decisions appropriately documented?” “Are complaint trends analyzed and reviewed?” and “Are complaint signals linked to CAPA investigations?”

Weak complaint handling systems often indicate deeper quality system problems. And conversely, strong complaint management programs demonstrate that a manufacturer actively monitors device performance and responds appropriately to potential risks.

Complaint Handling in the QMSR Era

The transition from QSR to QMSR does not eliminate complaint handling requirements. Instead, the ISO-aligned framework reinforces the importance of integrating complaint data into the broader quality management system.

Under QMSR, complaint handling should connect directly with CAPA investigations, risk management updates, internal audits, management review activities, and post-market surveillance processes.

Organizations that treat complaint handling as an isolated administrative task may struggle to meet these system-level expectations.

The Bottom Line

Complaint handling and post-market surveillance are essential tools for ensuring the continued safety and effectiveness of medical devices after they reach the market.

Under the QMSR framework, manufacturers must demonstrate not only that complaints are recorded and investigated, but also that post-market information is actively used to monitor risk, identify emerging quality issues, and improve the quality management system.

In a well-functioning quality system, complaint handling becomes more than regulatory compliance; it becomes a vital feedback mechanism for protecting patients and strengthening device performance over time.